<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Einstein (Sao Paulo)</journal-id>
      <journal-id journal-id-type="iso-abbrev">Einstein (Sao Paulo)</journal-id>
      <journal-id journal-id-type="publisher-id">eins</journal-id>
      <journal-title-group>
        <journal-title>Einstein</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1679-4508</issn>
      <issn pub-type="epub">2317-6385</issn>
      <publisher>
        <publisher-name>Instituto Israelita de Ensino e Pesquisa Albert Einstein</publisher-name>
        <publisher-loc>Sao Paulo</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24488396</article-id>
      <article-id pub-id-type="pmc">4880394</article-id>
      <article-id pub-id-type="publisher-id">S1679-45082013000400021</article-id>
      <article-id pub-id-type="doi">10.1590/S1679-45082013000400021</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Minimally invasive treatment of hepatic adenoma in special cases</article-title>
        <trans-title-group xml:lang="pt">
          <trans-title>Tratamento minimamente invasivo do adenoma hep&#xE1;tico em situa&#xE7;&#xF5;es especiais</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Nasser</surname>
            <given-names>Felipe</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Affonso</surname>
            <given-names>Breno Boueri</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Galastri</surname>
            <given-names>Francisco Leonardo</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Odisio</surname>
            <given-names>Bruno Calazans</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Garcia</surname>
            <given-names>Rodrigo Gobbo</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <aff id="aff1"><label>1</label>Hospital Israelita Albert Einstein, S&#xE3;o Paulo, SP, Brazil</aff>
        <aff id="aff2"><label>2</label>MD Anderson Cancer Center, Houston, United States</aff>
      </contrib-group>
      <author-notes>
        <corresp id="c1">Corresponding author: Francisco Leonardo Galastri &#x2013; Avenida Albert Einstein, 627/701 &#x2013; Morumbi &#x2013; Zip code: 05652-900 &#x2013; S&#xE3;o Paulo, SP, Brazil &#x2013; Phone: <phone>(55 11) 2151-0434</phone> &#x2013; E-mail: <email>francisco.galastri@einstein.br</email></corresp>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Oct-Dec</season>
        <year>2013</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Oct-Dec</season>
        <year>2013</year>
      </pub-date>
      <volume>11</volume>
      <issue>4</issue>
      <fpage>524</fpage>
      <lpage>527</lpage>
      <history>
        <date date-type="received">
          <day>15</day>
          <month>5</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>09</day>
          <month>10</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p> This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </license-p>
        </license>
      </permissions>
      <abstract>
        <title>ABSTRACT</title>
        <p>Hepatocellular adenoma is a rare benign tumor that was increasingly diagnosed in the 1980s and 1990s. This increase has been attributed to the widespread use of oral hormonal contraceptives and the broader availability and advances of radiological tests. We report two cases of patients with large hepatic adenomas who were subjected to minimally invasive treatment using arterial embolization. One case underwent elective embolization due to the presence of multiple adenomas and recent bleeding in one of the nodules. The second case was a victim of blunt abdominal trauma with rupture of a hepatic adenoma and clinical signs of hemodynamic shock secondary to intra-abdominal hemorrhage, which required urgent treatment. The development of minimally invasive locoregional treatments, such as arterial embolization, introduced novel approaches for the treatment of individuals with hepatic adenoma. The mortality rate of emergency resection of ruptured hepatic adenomas varies from 5 to 10%, but this rate decreases to 1% when resection is elective. Arterial embolization of hepatic adenomas in the presence of bleeding is a subject of debate. This observation suggests a role for transarterial embolization in the treatment of ruptured and non-ruptured adenomas, which might reduce the indication for surgery in selected cases and decrease morbidity and mortality. Magnetic resonance imaging showed a reduction of the embolized lesions and significant avascular component 30 days after treatment in the two cases in this report. No novel lesions were observed, and a reduction in the embolized lesions was demonstrated upon radiological assessment at a 12-month follow-up examination.</p>
      </abstract>
      <trans-abstract xml:lang="pt">
        <title>RESUMO</title>
        <p>O adenoma hepatocelular &#xE9; um tumor benigno raro, que apresentou aumento do n&#xFA;mero de diagn&#xF3;sticos nas d&#xE9;cadas de 1980 e 1990, o que foi atribu&#xED;do &#xE0; difus&#xE3;o dos contraceptivos hormonais orais, e &#xE0; melhor disponibiliza&#xE7;&#xE3;o e ao avan&#xE7;o dos exames radiol&#xF3;gicos. Apresentamos aqui o relato de dois pacientes com grandes adenomas hep&#xE1;ticos submetidos ao tratamento minimamente invasivo por meio de emboliza&#xE7;&#xE3;o arterial. O primeiro caso foi submetido &#xE0; emboliza&#xE7;&#xE3;o eletiva, por apresentar m&#xFA;ltiplos adenomas, al&#xE9;m de hemorragia recente de um desses n&#xF3;dulos. O segundo, caracterizado por v&#xED;tima de trauma abdominal fechado e rotura de adenoma hep&#xE1;tico, foi realizado em car&#xE1;ter de urg&#xEA;ncia, tendo a paciente sinais cl&#xED;nicos de choque hemodin&#xE2;mico secund&#xE1;rio &#xE0; hemorragia intra-abdominal. O desenvolvimento de terapias minimamente invasivas locorregionais, como a emboliza&#xE7;&#xE3;o arterial, trouxe um novo horizonte para pacientes com adenomas hep&#xE1;ticos. Na ressec&#xE7;&#xE3;o emergencial de um adenoma hep&#xE1;tico roto, as taxas de mortalidade s&#xE3;o de 5 a 10%, enquanto que a ressec&#xE7;&#xE3;o eletiva reduz a 1% esse desfecho. A emboliza&#xE7;&#xE3;o arterial dos adenomas hep&#xE1;ticos na vig&#xEA;ncia de hemorragia &#xE9; tema de debate. Essa constata&#xE7;&#xE3;o aponta para um poss&#xED;vel papel da emboliza&#xE7;&#xE3;o transarterial desses tumores rotos e n&#xE3;o rotos, visto que tal conduta poder&#xE1; limitar a indica&#xE7;&#xE3;o cir&#xFA;rgica em casos selecionados, resultando na redu&#xE7;&#xE3;o da morbimortalidade. O seguimento das pacientes tratadas foi realizado por meio de resson&#xE2;ncia magn&#xE9;tica e, ap&#xF3;s 30 dias, j&#xE1; havia diminui&#xE7;&#xE3;o das les&#xF5;es embolizadas bem como a presen&#xE7;a de significativo componente avascular. O controle radiol&#xF3;gico, ap&#xF3;s 12 meses, mostrou aus&#xEA;ncia de novas les&#xF5;es e diminui&#xE7;&#xE3;o daquelas embolizadas.</p>
      </trans-abstract>
      <kwd-group>
        <title>Keywords:</title>
        <kwd>Adenoma</kwd>
        <kwd>liver cells/therapy</kwd>
        <kwd>Embolization</kwd>
        <kwd>therapeutic</kwd>
        <kwd>Liver/injuries</kwd>
        <kwd>Case reports</kwd>
      </kwd-group>
      <counts>
        <fig-count count="8"/>
        <table-count count="0"/>
        <equation-count count="0"/>
        <ref-count count="10"/>
        <page-count count="4"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>The recent increase in the number of diagnosed solid liver lesions has been attributed to advances and wider availability of radiological testing<sup>(<xref rid="B1" ref-type="bibr">1</xref>)</sup>.</p>
      <p>Hepatocellular adenoma is a rare benign solid liver tumor of epithelial origin that primarily affects women of reproductive age. The prevalence of this adenoma increased remarkably in the 1980s and 1990s, which was attributed to the widespread use of oral hormonal contraceptives<sup>(<xref rid="B2" ref-type="bibr">2</xref>,<xref rid="B3" ref-type="bibr">3</xref>)</sup>. The incidence of hepatocellular carcinoma is 1 to 3/100,000 inhabitants/year in the general population according to current estimates<sup>(<xref rid="B4" ref-type="bibr">4</xref>)</sup>.</p>
      <p>We report two patients with large hepatic adenomas who were subjected to minimally invasive treatment using selective arterial embolization of the lesions. Elective embolization was indicated in one case due to the presence of multiple adenomas and a recent history of bleeding in one of the nodules. The other case was a victim of blunt abdominal trauma associated with the rupture of a previously unknown hepatic adenoma.</p>
    </sec>
    <sec>
      <title>CASE 1</title>
      <p>The first case was a 30-year-old female with a history of obesity and oral hormonal contraception use. She complained of sudden abdominal pain in the right hypochondrium without signs of peritoneal irritation in January 2011.</p>
      <p>Laboratory testing showed a reduced hemoglobin level and negative hepatitis B and C serology. Magnetic resonance imaging of the abdomen showed multiple solid, nodular, hypervascular lesions primarily in the right liver lobe, and a dense, heterogeneous, 10.1 &#xD7; 6.2cm structure in the caudate lobe, providing interface between the right and left liver lobes, compressing the inferior vena cava, dislocating the middle and right hepatic veins and the portal branches of the right lobe. The features of this lesion were compatible with intraparenchymal hematoma related to a bleeding hepatic adenoma.</p>
      <p>The patient remained asymptomatic during the outpatient follow-up period, but magnetic resonance imaging three months later revealed multiple hypervascular nodules scattered across both liver lobes, suggestive of new adenomas. Digital angiography of the liver confirmed the presence of multiple hypervascular lesions in the right liver lobes. Selective arterial embolization of the largest lesions in the right liver lobe was performed with 300- to 500-micron calibrated microspheres due to the high risk of bleeding and rupture (<xref ref-type="fig" rid="f1">Figure 1</xref>).</p>
      <fig id="f1" orientation="portrait" position="float">
        <label>Figure 1</label>
        <caption>
          <title>Angiography of the liver before and after embolization. Hypervascular lesions compatible with hepatic adenomas were observed in the liver right lobe, and these lesions are absent in the angiography after embolization</title>
        </caption>
        <graphic xlink:href="1679-4508-eins-11-04-0524-gf01"/>
      </fig>
      <p>Magnetic resonance imaging 30 days after embolization showed reduced embolized lesions and a significant avascular component. No new liver lesions were found on radiological images 12 months later, and the embolized lesions were smaller (<xref ref-type="fig" rid="f2">Figure 2</xref>).</p>
      <fig id="f2" orientation="portrait" position="float">
        <label>Figure 2</label>
        <caption>
          <title>Magnetic resonance imaging before embolization and one year later. Hypervascular lesions in the liver right lobe. The largest one is located in the caudate lobe with central necrosis and external compression of the inferior vena cava. The control magnetic resonance imaging exam performed one year after embolization shows a reduced hypervascular lesion in the caudate lobe, no external compression of the inferior vena cava, and no growth of the remaining hypervascular lesions</title>
        </caption>
        <graphic xlink:href="1679-4508-eins-11-04-0524-gf02"/>
      </fig>
    </sec>
    <sec>
      <title>CASE 2</title>
      <p>Case two was a 23-year-old female using oral hormonal contraception who suffered blunt abdominal trauma after falling two meters and hitting the right hypochondrium against a table. She complained of severe abdominal pain and exhibited signs of peritoneal irritation, skin and mucous membrane pallor, and hemodynamic shock.</p>
      <p>Laboratory testing showed a reduced hemoglobin level. Initial care in the emergency department, including fluid resuscitation and analgesia, controlled the hemodynamic shock. Computed tomography of the abdomen revealed the presence of multiple solid, hypervascular, nodular lesions, and liquefied hypoattenuating lesions mostly in segments VI and VII. The remainder of the approximately 10 lesions were primarily located in the liver right lobe, and the largest lesion was in segment II/III. The test also identified a large amount of free fluid beside the inferior liver margin and right paracolic gutter that extended to the pelvis. The lower margin of the liver lesions was slightly irregular, which suggested active bleeding into the peritoneum.</p>
      <p>The patient was transferred to the interventional radiology unit, and digital angiography of the liver was performed to confirm the presence of multiple hypervascular liver lesions. Selective arterial embolization of the largest lesions in the right lobe was performed with 300- to 500-micron calibrated microspheres (<xref ref-type="fig" rid="f3">Figure 3</xref>). The hemorrhage was stopped, and the hemodynamic conditions improved gradually. No new liver lesions were found on radiological images 12 months later, and the embolized lesions were smaller (<xref ref-type="fig" rid="f4">Figure 4</xref>).</p>
      <fig id="f3" orientation="portrait" position="float">
        <label>Figure 3</label>
        <caption>
          <title>Angiography of the liver before and after embolization. A large hypervascular lesion compatible with hepatic adenoma was observed in the liver right lobe, and the amputation of the intrahepatic arterial branches in the control exam after embolization is shown</title>
        </caption>
        <graphic xlink:href="1679-4508-eins-11-04-0524-gf03"/>
      </fig>
      <fig id="f4" orientation="portrait" position="float">
        <label>Figure 4</label>
        <caption>
          <title>Tomography of the abdomen before embolization and control magnetic resonance imaging one year later. A large hypervascular lesion is observed in the right liver lobe with a heterogeneous aspect suggestive of local hematoma, hypervascular lesions in the left liver lobe, and free fluid in the peritoneal cavity suggestive of abdominal hemorrhage. The magnetic resonance imaging exam one year later showed a significant reduction of the embolized lesions and the absence of new lesions</title>
        </caption>
        <graphic xlink:href="1679-4508-eins-11-04-0524-gf04"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>The present article reports two cases of hepatic adenomas that were treated using arterial embolization under two different clinical conditions. Arterial embolization in the first case was an elective treatment following an episode of self-limited, spontaneous hemorrhage. The second case was an emergency treatment due to the hemodynamic instability of a patient with bleeding adenoma following abdominal trauma. The therapy was successful in both cases. Bleeding did not relapse during the 12 month follow-up period, and the size of the treated lesions was substantially reduced.</p>
      <p>The development of minimally invasive locoregional treatments for the liver, such as arterial embolization and radiofrequency ablation, introduced new approaches for the management of individuals with non-ruptured hepatic adenomas<sup>(<xref rid="B5" ref-type="bibr">5</xref>)</sup>. However, individuals in whom hepatic adenomas negatively impact their quality of life or who exhibit signs of malignant conversion on imaging tests should be indicated for tumor resection.</p>
      <p>The mortality rates for the emergency resection of ruptured hepatic adenomas vary from 5 to 10%, but these rates are reduced to approximately 1% when resection is elective<sup>(<xref rid="B6" ref-type="bibr">6</xref>,<xref rid="B7" ref-type="bibr">7</xref>)</sup>. The indication for arterial embolization of hepatic adenomas in the presence of active bleeding is the subject of recent debate in the literature. The reduced mortality rate suggests a role for the transarterial embolization of tumors in the management of ruptured and non-ruptured hepatic adenomas. Follow-up examinations after embolization support the usefulness of this conservative treatment, which might reduce the indication for surgery in selected cases and decrease the morbidity and mortality. The exceptional nature of the treatment of the bleeding hepatic tumor elicited by blunt abdominal trauma further supports the usefulness of arterial embolization under different clinical conditions.</p>
      <p>Patients with hepatic adenomas should discontinue oral contraception because these tumors regress after these agents are interrupted<sup>(<xref rid="B8" ref-type="bibr">8</xref>,<xref rid="B9" ref-type="bibr">9</xref>)</sup>. Contrast imaging studies, such as tomography and magnetic resonance imaging, are crucial components of the patients' follow-up examinations<sup>(<xref rid="B10" ref-type="bibr">10</xref>)</sup>.</p>
      <p>In conclusion, transarterial embolization is an acceptable treatment for hepatic adenomas independent of the presence or absence of bleeding. The use of this therapy facilitates hemodynamic control in cases with bleeding and reduces tumor size. These findings should be confirmed in prospective multicenter studies.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Brunicardi</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Andersen</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Billiar</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Dunn</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Hunter</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Pollock</surname>
              <given-names>RE</given-names>
            </name>
          </person-group>
          <source>Schwartz's principles of surgery</source>
          <edition>8th ed.</edition>
          <publisher-loc>New York</publisher-loc>
          <publisher-name>McGraw-Hill Medical Publishing</publisher-name>
          <year>2004</year>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Belghiti</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Clavien</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Gadzijev</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Garden</surname>
              <given-names>JO</given-names>
            </name>
            <name>
              <surname>Lau</surname>
              <given-names>WY</given-names>
            </name>
            <name>
              <surname>Makuuchi</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The Brisbane 2000 terminology of liver anatomy and resections. Terminology committee of the International Hepato-Pancreato-Biliary Association</article-title>
          <source>HPB</source>
          <year>2000</year>
          <volume>2</volume>
          <issue>3</issue>
          <fpage>333</fpage>
          <lpage>339</lpage>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Botero</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Strasberg</surname>
              <given-names>SM</given-names>
            </name>
          </person-group>
          <article-title>Division of the left hemiliver in man-segments, sectors, or suctions</article-title>
          <source>Liver Transpl Surg</source>
          <year>1998</year>
          <volume>4</volume>
          <issue>3</issue>
          <fpage>226</fpage>
          <lpage>231</lpage>
          <pub-id pub-id-type="pmid">9563962</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Kasper</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Braunwald</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Hauser</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Longo</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Jameson</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Fauci</surname>
              <given-names>AS</given-names>
            </name>
          </person-group>
          <source>Harrison's principles of internal medicine</source>
          <edition>16th ed.</edition>
          <publisher-loc>New York</publisher-loc>
          <publisher-name>McGraw-Hill Medical Publishing</publisher-name>
          <year>2004</year>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huurman</surname>
              <given-names>VA</given-names>
            </name>
            <name>
              <surname>Schaapherder</surname>
              <given-names>AF</given-names>
            </name>
          </person-group>
          <article-title>Management of ruptured hepatocellular adenoma</article-title>
          <source>Dig Surg</source>
          <year>2010</year>
          <volume>27</volume>
          <issue>1</issue>
          <fpage>56</fpage>
          <lpage>60</lpage>
          <pub-id pub-id-type="pmid">20357452</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ault</surname>
              <given-names>GT</given-names>
            </name>
            <name>
              <surname>Wren</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Ralls</surname>
              <given-names>PW</given-names>
            </name>
            <name>
              <surname>Reynolds</surname>
              <given-names>TB</given-names>
            </name>
            <name>
              <surname>Stain</surname>
              <given-names>SC</given-names>
            </name>
          </person-group>
          <article-title>Selective management of hepatic adenomas</article-title>
          <source>Am Surg</source>
          <year>1996</year>
          <volume>62</volume>
          <issue>10</issue>
          <fpage>825</fpage>
          <lpage>829</lpage>
          <pub-id pub-id-type="pmid">8813164</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kammula</surname>
              <given-names>US</given-names>
            </name>
            <name>
              <surname>Buell</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Labow</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Rosen</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Millis</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Posner</surname>
              <given-names>MC</given-names>
            </name>
          </person-group>
          <article-title>Surgical management of benign tumors of the liver</article-title>
          <source>Int J Gastrointest Cancer</source>
          <year>2001</year>
          <volume>30</volume>
          <issue>3</issue>
          <fpage>141</fpage>
          <lpage>146</lpage>
          <pub-id pub-id-type="pmid">12540026</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van der Sluis</surname>
              <given-names>FJ</given-names>
            </name>
            <name>
              <surname>Bosch</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Terkivatan</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>de Man</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Ijzermans</surname>
              <given-names>JN</given-names>
            </name>
            <name>
              <surname>Hunink</surname>
              <given-names>MG</given-names>
            </name>
          </person-group>
          <article-title>Hepatocellular adenoma: cost-effectiveness of different treatment strategies</article-title>
          <source>Radiology</source>
          <year>2009</year>
          <volume>252</volume>
          <issue>3</issue>
          <fpage>737</fpage>
          <lpage>746</lpage>
          <pub-id pub-id-type="pmid">19717753</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deneve</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Pawlik</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Cunningham</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Clary</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Reddy</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Scoggins</surname>
              <given-names>CR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Liver cell adenoma: a multicenter analysis of risk factors for rupture and malignancy</article-title>
          <source>Ann Surg Oncol</source>
          <year>2009</year>
          <volume>169</volume>
          <issue>3</issue>
          <fpage>640</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">19130136</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zucman-Rossi</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Genetic alterations in hepatocellular adenomas: recent findings and new challenges</article-title>
          <source>J Hepatol</source>
          <year>2004</year>
          <volume>40</volume>
          <issue>6</issue>
          <fpage>1036</fpage>
          <lpage>1039</lpage>
          <pub-id pub-id-type="pmid">15158349</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
